This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2017-11-08 SGB Conference Call"

From HL7Wiki
Jump to navigation Jump to search
Line 78: Line 78:
 
*Approve Minutes of [[2017-10-25_SGB_Conference_Call]]
 
*Approve Minutes of [[2017-10-25_SGB_Conference_Call]]
 
*Action Items
 
*Action Items
 +
**Review GOM with respect to where SGB and precepts should be reflected
 +
**Recommend to TSC to work with CTO on architecture and tooling strategy to support the work of the committees in following the precepts
 +
**Ask Vocab to approve a motion that it was the WG’s intention in R3 for the Expansion profile to be balloted as STU. If PA has not documented approval, send them the same message
 +
**Paul to verify with Karen that the documentation on the FHIR R3 ballot STU approvals is sufficient
 
*Discussion Topics
 
*Discussion Topics
 +
**Finish review of mixed ballot content precept
 +
**Precept implementation strategy
 +
**Backwards compatibility consistency and definition across families
 +
*[http://wiki.hl7.org/index.php?title=List_of_Precepts_Under_Development Precepts to Develop]
 
*Parking Lot
 
*Parking Lot
 +
**Review Publishing M&C updates regarding dual roles
 +
**How do we deal with making sure that WGs involve those whose content domain they’re touching? (CIMI and Pharmacy and Lab models)
 +
**Review Mission and Charter
 +
**Handling situations where two documents come out of one project
 +
**[http://wiki.hl7.org/index.php?title=FHIR_Product_Director_Page FHIR Product Director Position Description]: we should 1) review further and draft feedback, then 2) map back the description to the role of FGB
 +
**Drafting Shared Product Management Responsibilities
 +
**Levels of standards
 +
**Separation of concerns
 +
**Ownership of content
 +
**ISM
 +
**Ask methodology groups to define how the definition of substantive change applies to their product family; management groups must then operationalize
  
 
===Minutes===
 
===Minutes===

Revision as of 22:17, 6 November 2017

back to Standards Governance Board main page

HL7 SGB Minutes

Location:
https://global.gotomeeting.com/join/538465637

Date: 2017-11-08
Time: 10:00 AM Eastern
Facilitator Paul/Calvin Note taker(s) Anne
Attendee Name


Calvin Beebe
Lorraine Constable
Russ Hamm
Tony Julian
Paul Knapp
Austin Kreisler
Wayne Kubick
Thom Kuhn
Ken McCaslin
Rik Smithies
Sandy Stuart
Quorum: Chair + 4

Agenda

  • Agenda review
  • Approve Minutes of 2017-10-25_SGB_Conference_Call
  • Action Items
    • Review GOM with respect to where SGB and precepts should be reflected
    • Recommend to TSC to work with CTO on architecture and tooling strategy to support the work of the committees in following the precepts
    • Ask Vocab to approve a motion that it was the WG’s intention in R3 for the Expansion profile to be balloted as STU. If PA has not documented approval, send them the same message
    • Paul to verify with Karen that the documentation on the FHIR R3 ballot STU approvals is sufficient
  • Discussion Topics
    • Finish review of mixed ballot content precept
    • Precept implementation strategy
    • Backwards compatibility consistency and definition across families
  • Precepts to Develop
  • Parking Lot
    • Review Publishing M&C updates regarding dual roles
    • How do we deal with making sure that WGs involve those whose content domain they’re touching? (CIMI and Pharmacy and Lab models)
    • Review Mission and Charter
    • Handling situations where two documents come out of one project
    • FHIR Product Director Position Description: we should 1) review further and draft feedback, then 2) map back the description to the role of FGB
    • Drafting Shared Product Management Responsibilities
    • Levels of standards
    • Separation of concerns
    • Ownership of content
    • ISM
    • Ask methodology groups to define how the definition of substantive change applies to their product family; management groups must then operationalize

Minutes

Meeting Outcomes

Actions
Next Meeting/Preliminary Agenda Items

© 2017 Health Level Seven® International. All rights reserved